The United States market has shown positive momentum, rising 1.0% over the last week and 18% over the past year, with earnings projected to grow by 17% annually. In this environment, identifying small-cap stocks that may be undervalued can offer unique opportunities for investors looking to capitalize on potential growth.

Top 10 Undervalued Small Caps With Insider Buying In The United States

Name	PE	PS	Discount to Fair Value	Value Rating
Bank of the James Financial Group	10.9x	2.4x	26.60%	★★★★☆☆
German American Bancorp	13.5x	5.0x	24.04%	★★★☆☆☆
HireQuest	27.4x	7.7x	21.61%	★★★☆☆☆
Union Bankshares	9.9x	2.1x	18.27%	★★★☆☆☆
Shore Bancshares	12.1x	3.5x	33.82%	★★★☆☆☆
Similarweb	NA	2.7x	-32.58%	★★★☆☆☆
Orion Group Holdings	111.6x	0.4x	43.89%	★★★☆☆☆
AVITA Medical	NA	3.3x	-8.58%	★★★☆☆☆
Chain Bridge Bancorp	12.0x	4.8x	48.48%	★★★☆☆☆
Cardinal Infrastructure Group	NA	1.3x	23.79%	★★★☆☆☆

Let's review some notable picks from our screened stocks.

AVITA Medical (RCEL)

Simply Wall St Value Rating: ★★★☆☆☆

Overview: AVITA Medical specializes in regenerative medicine and develops innovative skin restoration solutions, with a market cap of approximately $0.25 billion.

Operations: AVITA Medical's primary revenue stream is from Recell Devices, with the latest reported revenue at $75.63 million. The company has a gross profit margin of 81.56%, reflecting its efficiency in managing production costs relative to sales. Operating expenses are significant, driven by high sales and marketing expenditures, alongside research and development efforts.

PE: -5.8x

AVITA Medical, a small company in the U.S., is gaining attention for its potential growth despite recent volatility and past shareholder dilution. The company's second-quarter revenue rose to US$21.7 million from US$18.42 million last year, while losses narrowed to US$7.66 million from US$9.92 million. Recent insider confidence was evident with share purchases earlier this year, indicating belief in future prospects as they raised their 2026 revenue guidance to between US$86-89 million, reflecting anticipated growth of 20% to 24%.

Value Line (VALU)

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Value Line is a company primarily engaged in publishing investment-related periodicals and reports, with a market capitalization of approximately $0.54 billion.

Operations: The company generates revenue primarily through its publishing segment, amounting to $33.45 million. Over recent periods, the net income margin has shown an upward trend, reaching 64.67%. Operating expenses are a significant part of costs, with general and administrative expenses consistently forming a substantial portion of these costs.

PE: 16.6x

Value Line, a smaller U.S. company, saw earnings per share rise to US$2.3 for the year ending April 2026, despite revenue slipping to US$33.45 million from the previous year. Insider confidence is evident as they initiated a share buyback program in July 2026 worth up to US$2 million with no expiration date. However, being dropped from several Russell indices in June 2026 may impact visibility and investor interest moving forward.

Trinity Capital (TRIN)

Simply Wall St Value Rating: ★★★★★☆

Overview: Trinity Capital is a business development company that primarily provides debt and equity capital to growth-stage companies, with a market capitalization of approximately $0.58 billion.

Operations: The company's revenue is entirely derived from its venture capital segment, reaching $313.05 million as of the latest period. Operating expenses stand at $75.98 million, contributing to a net income margin of 45.15%. The gross profit margin consistently remains at 100% over multiple periods, indicating no cost of goods sold reported in financials.

PE: 12.3x

Trinity Capital, operating in a niche market, recently reported Q2 revenue of US$87.17 million, up from US$69.48 million the previous year, yet earnings per share fell to US$0.49 from US$0.63. With insider confidence evident through recent purchases and a strategic shift to the New York Stock Exchange by July's end, the company signals potential growth despite its removal from the NASDAQ Composite Index on July 24th and reliance on external borrowing for funding.

Key Takeaways

• Take a closer look at our Undervalued US Small Caps With Insider Buying list of 71 companies by clicking here.
• Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
• Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.